<!DOCTYPE html><html><head><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><meta name="generator" content="Gatsby 2.30.1"/><title data-react-helmet="true">Lymphocyte Disorders and Lymphoid Leukemias | Kwat</title><link data-react-helmet="true" rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bulma@0.9.1/css/bulma.min.css"/><link data-react-helmet="true" rel="stylesheet" href="https://use.fontawesome.com/releases/v5.7.2/css/all.css" integrity="sha384-fnmOCqbTlWIlj8LyTjo7mOUStjsKC4pOpQbqyi7RrhN7udi9RwhKkMHpvLbHG9Sr" crossorigin="anonymous"/><link data-react-helmet="true" rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"/><meta data-react-helmet="true" name="description" content="Website of Kwat Medetgul-Ernar"/><meta data-react-helmet="true" property="og:title" content="Lymphocyte Disorders and Lymphoid Leukemias | Kwat"/><meta data-react-helmet="true" property="og:description" content="Website of Kwat Medetgul-Ernar"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" name="twitter:card" content="summary"/><meta data-react-helmet="true" name="twitter:creator" content="Kwat Medetgul-Ernar"/><meta data-react-helmet="true" name="twitter:title" content="Lymphocyte Disorders and Lymphoid Leukemias | Kwat"/><meta data-react-helmet="true" name="twitter:description" content="Website of Kwat Medetgul-Ernar"/><link rel="icon" href="/favicon-32x32.png?v=3819308f81da541a8f9f3564c9a3d099" type="image/png"/><link rel="manifest" href="/manifest.webmanifest" crossorigin="anonymous"/><meta name="theme-color" content="#20d9ba"/><link rel="apple-touch-icon" sizes="48x48" href="/icons/icon-48x48.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="72x72" href="/icons/icon-72x72.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="96x96" href="/icons/icon-96x96.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="144x144" href="/icons/icon-144x144.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="192x192" href="/icons/icon-192x192.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="256x256" href="/icons/icon-256x256.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="384x384" href="/icons/icon-384x384.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="apple-touch-icon" sizes="512x512" href="/icons/icon-512x512.png?v=3819308f81da541a8f9f3564c9a3d099"/><link rel="preconnect" href="https://www.google-analytics.com"/><link rel="dns-prefetch" href="https://www.google-analytics.com"/><script>
  
  
  if(true) {
    (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
    (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
    m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
    })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  }
  if (typeof ga === "function") {
    ga('create', 'UA-186228916-1', 'auto', {});
      
      
      
      
      
      }</script><link as="script" rel="preload" href="/webpack-runtime-02a4af453d6bde48b91c.js"/><link as="script" rel="preload" href="/framework-6c3ead24af170cdcb87c.js"/><link as="script" rel="preload" href="/app-9fb4caefe823046253f0.js"/><link as="script" rel="preload" href="/commons-943907512df6b4e50a44.js"/><link as="script" rel="preload" href="/component---src-templates-post-jsx-b1ce5b86ea3cc453e2da.js"/><link as="fetch" rel="preload" href="/page-data/posts/Lymphocyte Disorders and Lymphoid Leukemias/page-data.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="/page-data/sq/d/1003640200.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="/page-data/sq/d/893747738.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="/page-data/app-data.json" crossorigin="anonymous"/></head><body><div id="___gatsby"><div style="outline:none" tabindex="-1" id="gatsby-focus-wrapper"><div style="display:flex;flex-direction:column;min-height:100vh"><nav class="navbar" role="navigation" aria-label="main navigation"><span class="navbar-brand"><a class="navbar-item" href="/"><p class="is-size-4 has-text-weight-bold">~</p></a><button class="navbar-burger button is-white " type="button" aria-label="menu" aria-expanded="false"><span aria-hidden="true"></span><span aria-hidden="true"></span><span aria-hidden="true"></span></button></span><span class="navbar-menu "><span class="navbar-start"><a class="navbar-item" href="/about">About</a><a class="navbar-item" href="/posts">Posts</a></span><span class="navbar-end"><a class="navbar-item" href="https://github.com/KwatME" target="_blank" rel="noreferrer"><i class="fab fa-github"></i></a><a class="navbar-item" href="https://scholar.google.com/citations?user=PAM4lScAAAAJ&amp;hl" target="_blank" rel="noreferrer"><i class="ai ai-google-scholar ai-lg"></i></a><a class="navbar-item" href="https://anchor.fm/Kwat" target="_blank" rel="noreferrer"><i class="fa fa-podcast"></i></a><a class="navbar-item" href="https://www.youtube.com/channel/UCYDeuExg0JHfKj4CfjQ260A" target="_blank" rel="noreferrer"><i class="fab fa-youtube"></i></a><a class="navbar-item" href="https://twitter.com/KwatME" target="_blank" rel="noreferrer"><i class="fab fa-twitter"></i></a><a class="navbar-item" href="https://www.instagram.com/Kwat.ME" target="_blank" rel="noreferrer"><i class="fab fa-instagram"></i></a><a class="navbar-item" href="https://stanford.zoom.us/my/kwatme?pwd=Q2dzVXUwdmhuZzg2Vkc4aFliSFFnQT09" target="_blank" rel="noreferrer"><i class="fa fa-phone"></i></a></span></span></nav><main role="main" style="flex:1"><section class="section"><div class="container" style="max-width:800px"><h1 class="title is-2">Lymphocyte Disorders and Lymphoid Leukemias</h1><div class=" gatsby-image-wrapper" style="position:relative;overflow:hidden"><div aria-hidden="true" style="width:100%;padding-bottom:50%"></div><img aria-hidden="true" src="data:image/jpeg;base64,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" alt="" style="position:absolute;top:0;left:0;width:100%;height:100%;object-fit:cover;object-position:center;opacity:1;transition-delay:500ms"/><noscript><picture><source type='image/webp' srcset="/static/23b98f1a766c041e71c1aa8d7bc612dd/6b183/cover.webp 200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/fc32b/cover.webp 400w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/ccdb5/cover.webp 800w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/9000d/cover.webp 1200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/e0075/cover.webp 1600w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/60b4e/cover.webp 1800w" sizes="(max-width: 800px) 100vw, 800px" /><source srcset="/static/23b98f1a766c041e71c1aa8d7bc612dd/fd013/cover.jpg 200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/25252/cover.jpg 400w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/2f1b1/cover.jpg 800w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/0ff54/cover.jpg 1200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/06655/cover.jpg 1600w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/b53a4/cover.jpg 1800w" sizes="(max-width: 800px) 100vw, 800px" /><img loading="lazy" sizes="(max-width: 800px) 100vw, 800px" srcset="/static/23b98f1a766c041e71c1aa8d7bc612dd/fd013/cover.jpg 200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/25252/cover.jpg 400w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/2f1b1/cover.jpg 800w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/0ff54/cover.jpg 1200w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/06655/cover.jpg 1600w,
/static/23b98f1a766c041e71c1aa8d7bc612dd/b53a4/cover.jpg 1800w" src="/static/23b98f1a766c041e71c1aa8d7bc612dd/2f1b1/cover.jpg" alt="" style="position:absolute;top:0;left:0;opacity:1;width:100%;height:100%;object-fit:cover;object-position:center"/></picture></noscript></div><div class="columns is-vcentered mt-1"><div class="column"><section class="heading subtitle is-6"><p><time>January 22, 2021</time></p><p>470 words<!-- --> |<!-- --> <!-- -->2 minutes</p></section></div><div class="column"><section class="is-pulled-right heading subtitle is-6"><a href="/tags/Medicine">Medicine</a>, <a href="/tags/Hematologic">Hematologic</a></section></div></div><div class="content"><h2>Leukemia is the cancer of developing lymphocytes and granulocytes.</h2>
<p>When a premature lymphocyte (B or T) meeses up its differentiation and becomes a cancer cell, then the cancer cell is called leukemia cell.</p>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 574px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 87.5%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="source"
        title="source"
        src="/static/a5969da11f22da77c5440b3bed4e8983/86389/source.png"
        srcset="/static/a5969da11f22da77c5440b3bed4e8983/772e8/source.png 200w,
/static/a5969da11f22da77c5440b3bed4e8983/e17e5/source.png 400w,
/static/a5969da11f22da77c5440b3bed4e8983/86389/source.png 574w"
        sizes="(max-width: 574px) 100vw, 574px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<h2>Leukemia lymphocytes look different.</h2>
<p>Compared to a healthy lymphocyte, a leukemia lymphocyte has more accessible chromatin and more cytoplasm.
Perhaps these cells are making more stuff.</p>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 390px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 65.49999999999999%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="reactivel"
        title="reactivel"
        src="/static/4cee4b3c90ec875ad2193af228103493/727ba/reactivel.png"
        srcset="/static/4cee4b3c90ec875ad2193af228103493/772e8/reactivel.png 200w,
/static/4cee4b3c90ec875ad2193af228103493/727ba/reactivel.png 390w"
        sizes="(max-width: 390px) 100vw, 390px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 392px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 64.99999999999999%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="leukemial"
        title="leukemial"
        src="/static/a921efd2b4f124740156ec80e89fa3d3/0acb4/leukemial.png"
        srcset="/static/a921efd2b4f124740156ec80e89fa3d3/772e8/leukemial.png 200w,
/static/a921efd2b4f124740156ec80e89fa3d3/0acb4/leukemial.png 392w"
        sizes="(max-width: 392px) 100vw, 392px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<p>Lymphocytes can look like monocytes.</p>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 640px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 66%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="lymphocyteormonocyte"
        title="lymphocyteormonocyte"
        src="/static/6f07df5e5c726393f35224717247488d/6af66/lymphocyteormonocyte.png"
        srcset="/static/6f07df5e5c726393f35224717247488d/772e8/lymphocyteormonocyte.png 200w,
/static/6f07df5e5c726393f35224717247488d/e17e5/lymphocyteormonocyte.png 400w,
/static/6f07df5e5c726393f35224717247488d/6af66/lymphocyteormonocyte.png 640w"
        sizes="(max-width: 640px) 100vw, 640px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<h2>In a normal process like infection, your body also makes more lymphocytes.</h2>
<p>Specific infection results in lymphocytosis.
EBV infects B cells.
The body responds by making more T cells that can eliminate the infected B cells.
This expansion of a specific T cell population in response to an infection is called infectious mononucleosis.</p>
<p>A patient infected by EBV presents with:</p>
<ul>
<li>Sore throat</li>
<li>Fever</li>
<li>Posterior lymphoadenopathy</li>
<li>Hepatosplenomegaly</li>
<li>Rash</li>
</ul>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 392px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 64%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="ebvthroat"
        title="ebvthroat"
        src="/static/c5eb54a3fb654d11dce3ea89ca0fc788/0acb4/ebvthroat.png"
        srcset="/static/c5eb54a3fb654d11dce3ea89ca0fc788/772e8/ebvthroat.png 200w,
/static/c5eb54a3fb654d11dce3ea89ca0fc788/0acb4/ebvthroat.png 392w"
        sizes="(max-width: 392px) 100vw, 392px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 391px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 64.99999999999999%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="ebvrash"
        title="ebvrash"
        src="/static/473f66189e74a0ea34c676a8ed9a4378/14e0c/ebvrash.png"
        srcset="/static/473f66189e74a0ea34c676a8ed9a4378/772e8/ebvrash.png 200w,
/static/473f66189e74a0ea34c676a8ed9a4378/14e0c/ebvrash.png 391w"
        sizes="(max-width: 391px) 100vw, 391px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<p>Monospot test is positive for EBV infected patients.</p>
<h2>Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.</h2>
<p>ALL is the cancer of immature lymphocytes.</p>
<p>1 in 2000 kids get this.
60% of ALL patients are under 20.</p>
<p>Treatment is chemotherapy, CNS prophylaxis, immunotherapy, and or marrow transplant.</p>
<p>Blinatumumab is an antibody against cancer cell.
This antibody can also bind to T cell.
The antibody brings together a cancer cell and a T cell so the T cell can eliminate the cancer cell.</p>
<p>Inotuzumab Ozogamicin is also an antibody against cancer cell.
This antibody carries toxins that can penetrate into the bound cancer cell and damage it.</p>
<p>Chimetic antigen receptor T cell is an engineered T cell that recognizes and eliminates cancer cells.
A patient's own T cell is manipulated to be able to react to the cancer cell.</p>
<h2>Philadelphia chromosome is a specific mutation assocaited with leukemia.</h2>
<p>This mutation fuses BCR and ABL genes in a B cell.
This fusion results in BCR promotor, which is more active, controlling ABL gene, which is an oncogene.
As a result, the B cells with this mutaion make more oncogene.</p>
<p>Luckily, there is BCR-ABL inhibitors like imatinib and dasatinib, which are effective against B cell leukemias with this mutation.</p>
<h2>Chronic lymphocytic leukemia (CLL) is the most common adult leukemia.</h2>
<p>CLL is the cancer of mature lymphocytes.</p>
<p>Averate onset is 70.
Most patients are asymptomatic at diagnosis.
Symptoms can be mild, in which patients die from other typical causes.
Symptoms can also be severe, in which the patients die from the CLL in few years.</p>
<h2>There are many types of chronic lymphoproliferative disorders.</h2>
<ul>
<li>Hairy cell leukemia (BRAF mutation, hairy cell, cytopenia with splenomegaly, good prognosis)</li>
</ul>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 397px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 101%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="hcl"
        title="hcl"
        src="/static/834c53fbd73f7d3fbf54eb5ad27a3418/4c04a/hcl.png"
        srcset="/static/834c53fbd73f7d3fbf54eb5ad27a3418/772e8/hcl.png 200w,
/static/834c53fbd73f7d3fbf54eb5ad27a3418/4c04a/hcl.png 397w"
        sizes="(max-width: 397px) 100vw, 397px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<ul>
<li>Prolymphocytic leukemia (T cell origin is aggressive, B cell origin is from CLL, splenomegaly)</li>
</ul>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 408px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 100.49999999999999%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="pll"
        title="pll"
        src="/static/8100c2a599bcfeaa1570aa3c6a23076a/e7c18/pll.png"
        srcset="/static/8100c2a599bcfeaa1570aa3c6a23076a/772e8/pll.png 200w,
/static/8100c2a599bcfeaa1570aa3c6a23076a/e17e5/pll.png 400w,
/static/8100c2a599bcfeaa1570aa3c6a23076a/e7c18/pll.png 408w"
        sizes="(max-width: 408px) 100vw, 408px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<ul>
<li>Large granular lymphoproliferative disorders (T or NK cell origin, big cytoplasm with granules [T cells have granules], only neutropenia [T cells deplete the resources for making granules])</li>
</ul>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 455px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 80%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="lgl"
        title="lgl"
        src="/static/51deebc14b872b7055a8ebcb2a0f574d/379c3/lgl.png"
        srcset="/static/51deebc14b872b7055a8ebcb2a0f574d/772e8/lgl.png 200w,
/static/51deebc14b872b7055a8ebcb2a0f574d/e17e5/lgl.png 400w,
/static/51deebc14b872b7055a8ebcb2a0f574d/379c3/lgl.png 455w"
        sizes="(max-width: 455px) 100vw, 455px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p>
<ul>
<li>Adult T cell leukemia-lymphoma (HTLV-1 infection, cloverleaf nuclei, endemic in Japan and Carribean, aggressive, hepatosplenomegaly, lymphoadenopathy)</li>
</ul>
<p><span
      class="gatsby-resp-image-wrapper"
      style="position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 492px; "
    >
      <span
    class="gatsby-resp-image-background-image"
    style="padding-bottom: 64.99999999999999%; position: relative; bottom: 0; left: 0; background-image: url('data:image/png;base64,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'); background-size: cover; display: block;"
  ></span>
  <img
        class="gatsby-resp-image-image"
        alt="atll"
        title="atll"
        src="/static/88d6fd273cd473c62883c62fbf2eef7d/5c6e9/atll.png"
        srcset="/static/88d6fd273cd473c62883c62fbf2eef7d/772e8/atll.png 200w,
/static/88d6fd273cd473c62883c62fbf2eef7d/e17e5/atll.png 400w,
/static/88d6fd273cd473c62883c62fbf2eef7d/5c6e9/atll.png 492w"
        sizes="(max-width: 492px) 100vw, 492px"
        style="width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;"
        loading="lazy"
      />
    </span></p></div></div></section></main><footer class="footer pb-6" role="contentinfo"><div class="columns has-text-centered-touch"><div class="column"><section class="has-text-left-desktop"><p class="has-text-weight-medium is-italic">Opinions are my own.</p></section></div><div class="column"><section class="has-text-right-desktop"><p class="has-text-weight-medium">Kwat Medetgul-Ernar<!-- --> © <!-- -->2021</p></section></div></div></footer></div></div><div id="gatsby-announcer" style="position:absolute;top:0;width:1px;height:1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border:0" aria-live="assertive" aria-atomic="true"></div></div><script id="gatsby-script-loader">/*<![CDATA[*/window.pagePath="/posts/Lymphocyte Disorders and Lymphoid Leukemias/";/*]]>*/</script><script id="gatsby-chunk-mapping">/*<![CDATA[*/window.___chunkMapping={"polyfill":["/polyfill-48e56cca0128f3598c84.js"],"app":["/app-9fb4caefe823046253f0.js"],"component---src-pages-404-index-jsx":["/component---src-pages-404-index-jsx-90df8fb73527fd2b1559.js"],"component---src-pages-about-index-jsx":["/component---src-pages-about-index-jsx-8746886e75820267df1d.js"],"component---src-pages-index-jsx":["/component---src-pages-index-jsx-90a985398f981a926dd4.js"],"component---src-pages-posts-index-jsx":["/component---src-pages-posts-index-jsx-c28f38a2a1a2b9dfb5b6.js"],"component---src-templates-post-jsx":["/component---src-templates-post-jsx-b1ce5b86ea3cc453e2da.js"],"component---src-templates-poststag-jsx":["/component---src-templates-poststag-jsx-395ce50e3e6e858ef1cb.js"]};/*]]>*/</script><script src="/polyfill-48e56cca0128f3598c84.js" nomodule=""></script><script src="/component---src-templates-post-jsx-b1ce5b86ea3cc453e2da.js" async=""></script><script src="/commons-943907512df6b4e50a44.js" async=""></script><script src="/app-9fb4caefe823046253f0.js" async=""></script><script src="/framework-6c3ead24af170cdcb87c.js" async=""></script><script src="/webpack-runtime-02a4af453d6bde48b91c.js" async=""></script></body></html>